rufinamide
rufinamide is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including Banzel, RUFINAMIDE, rufinamide. Available dosage forms: tablet, film coated, powder, suspension.
Drug Details
- Generic Name
- rufinamide
- Brand Names
- Banzel, RUFINAMIDE, rufinamide, Rufinamide
- Application Number
- NDA021911
- Sponsor
- Eisai Inc.
- NDC Codes
- 11
- Dosage Forms
- TABLET, FILM COATED, POWDER, SUSPENSION
- Routes
- ORAL
- Active Ingredients
- RUFINAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults. Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults ( 1 )